Forex (FX) Trading: Currency traders rely heavily on accurate and up-to-date exchange rates. A currency converter app provides real-time rates, charts, and analysis, helping traders make timely ...

We identified Manitobans with MS from 1984 to 2016 using a validated definition relying on health claims; the earliest demyelinating disease claim constituted the index date ... Among incident opioid ...

A new study led by the University of South Florida reveals opioid control policies may offer broader public health benefits, ...

Viatris (VTRS, Financials) will pay up to $335 million in annual installments over nine years to settle opioid-related claims from U.S. states, local governments, and tribal entities, the company ...

Viatris has agreed to a settlement in which it will pay up to $335 million to resolve opioid-related claims to state and local governments, the Pittsburgh-based generics specialist said on Monday.

A groundbreaking study conducted by neonatologists has revealed that babies exposed to opioids in the womb tend to have ...

Viatris has agreed to pay as much as $335 million to settle claims regarding its sale of opioids. The Pittsburgh pharmaceutical company said Monday it was not admitting wrongdoing, but had agreed ...

This crisis doesn’t discriminate. It affects working parents, young people and seniors — many of whom end up dependent ...

Viatris (NASDAQ:VTRS) has agreed to pay up to a maximum of $335M as part of a nationwide settlement to resolve opioid-related claims. The amount consists of annual payments over a nine-year period ...

Mylan, which in 2020 merged with a division of Pfizer to form the new company Viatris, has manufactured and sold a variety of opioids since ... Viatris will pay up to $335 million to participating ...

The Canonsburg-based pharmaceutical firm joins other industry giants in addressing opioid-related claims. Viatris will spend as much as $335 million to settle opioid-related claims against the ...